More EMvision Medical Devices Ltd. news
EMvision Medical Devices Ltd.ASX: EMV

S&P DJI Announces March 2026 Quarterly Rebalance

Mar 6, 2026 at 6:26 AM EST · Issued by EMvision Medical Devices Ltd.

Filed with ASX · Mar 6, 2026 at 6:26 AM EST · 7 pages · English

On 6ix: 6ix.com/news/sandp-dji-announces-march-2026-quarterly-rebalance-77

EMvision Medical Devices Ltd. on 6ix

Story so far

  • S&P DJI Announces March 2025 Quarterly RebalanceMar 7, 2025

Earlier from EMvision Medical Devices

  • EMVision Medical Devices to Present at Australia Investor Day February 26thFeb 24
  • Half Yearly Report and AccountsFeb 22
  • Quarterly Activities/Appendix 4C Cash Flow ReportJan 27
  • Strong emu Clinical Trial & Program ProgressJan 26
  • First Responder Aeromedical Study CommencesNov 26, 2025

Later from EMvision Medical Devices

  • Update - S&P DJI March 2026 Rebalance of the All OrdinariesMar 10
  • $3.8m R&D Rebate Received & Overseas Finding ApprovedMar 15
  • emu Pivotal Trial Expansion Adds Acute Ischaemia DetectionMay 10
  • EMVision to Receive $1.17M IGP Grant InstalmentMay 24
  • Aeromedical Study De-Risks Rural & Remote Stroke Use CasesMay 26
All EMvision Medical Devices news releases↗

Follow EMvision Medical Devices into a list and get an email when it puts out news.

Follow EMvision Medical Devices
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer